End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
78,400 KRW | -4.16% | +4.53% | +13.95% |
May. 16 | Yuhan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
Business Summary
Number of employees: 1,999
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals, Chemicals, Industrial Drugs, Veterinary Drugs, Household Goods, Etc.
100.0
%
| 1,775,847 | 100.0 % | 1,858,984 | 100.0 % | +4.68% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea, United States, Hong Kong, Australia, and Uzbekistan
100.0
%
| 1,775,847 | 100.0 % | 1,858,984 | 100.0 % | +4.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wuk-Jae Cho
CEO | Chief Executive Officer | 69 | 87-04-30 |
Jeong-Hui Lee
CHM | Chairman | 72 | 78-04-30 |
Yeol-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | 65 | 23-02-28 |
Byeong-Man Lee
BRD | Director/Board Member | 66 | - |
Tae-Jin Yoon
PRN | Corporate Officer/Principal | 54 | 15-07-31 |
Byung-Chul Lee
AUD | Comptroller/Controller/Auditor | 60 | 92-03-31 |
Young-Rae Lee
PRN | Corporate Officer/Principal | 63 | 87-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeong-Hui Lee
CHM | Chairman | 72 | 78-04-30 |
Wuk-Jae Cho
CEO | Chief Executive Officer | 69 | 87-04-30 |
Byeong-Man Lee
BRD | Director/Board Member | 66 | - |
Yeong-Jae Shin
BRD | Director/Board Member | 57 | 21-03-18 |
Young-Rae Lee
PRN | Corporate Officer/Principal | 63 | 87-02-28 |
Dong-Jin Park
BRD | Director/Board Member | 59 | - |
Seong-Gil Ji
BRD | Director/Board Member | 61 | 20-03-19 |
Jun-Chul Kim
BRD | Director/Board Member | 59 | 21-03-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 80,209,064 | 54,770,208 ( 68.28 %) | 6,415,129 ( 7.998 %) | 67.29 % |
Stock B | 0 | 1,180,940 | 0 | 32,600 ( 2.761 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
YUHAN CORPORATION 8.35% | 6,697,798 | 8.35% | 332,821,888 $ |
APRILBIO CO.,LTD. 9.92% | 2,155,750 | 9.92% | 22,000,464 $ |
GI INNOVATION, INC. 3.54% | 1,566,060 | 3.54% | 13,132,040 $ |
PROGEN CO., LTD. 18.13% | 2,095,002 | 18.13% | 9,230,076 $ |
THERAGEN ETEX CO.,LTD. 7.71% | 2,503,128 | 7.71% | 6,951,387 $ |
GENEXINE, INC. 1.18% | 491,570 | 1.18% | 2,524,330 $ |
62,500 | 2.19% | 92,500 $ |
Company contact information
Sector
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.95% | 4.27B | |
+19.29% | 80.29B | |
+15.06% | 9.2B | |
-18.33% | 4.67B | |
+43.39% | 4.49B | |
+10.89% | 2.25B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A000100 Stock
- Company Yuhan Corporation